- /
- Supported exchanges
- / US
- / WST.NYSE
West Pharmaceutical Services Inc (WST NYSE) stock market data APIs
West Pharmaceutical Services Inc Financial Data Overview
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with West Pharmaceutical Services Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get West Pharmaceutical Services Inc data using free add-ons & libraries
Get West Pharmaceutical Services Inc Fundamental Data
West Pharmaceutical Services Inc Fundamental data includes:
- Net Revenue: 3 327 M
- EBITDA: 912 M
- Earnings Per Share: 7
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get West Pharmaceutical Services Inc Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-07-23
- EPS/Forecast: 2.08
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
West Pharmaceutical Services Inc News
New
Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST)
Drug Development Inputs & Services Stocks Q2 Highlights: West Pharmaceutical Services (NYSE:WST) Quarterly earnings results are a good time to check in on a company's progress, especially compared to...
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care
Smith+Nephew SNN recently launched the new EVOS PELVIC Plating System, expanding its EVOS trauma platform into pelvic and acetabular fracture management. The launch strengthens the company's orthopedi...
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
Integer Holdings Corporation ITGR has been gaining from its research and product development activities. The optimism, led by a mixed second-quarter 2026 performance and its strength in core product f...
Here's Why You Should Retain BDX Stock in Your Portfolio for Now
Becton, Dickinson and Company BDX is benefiting from its focused transformation into a pure-play MedTech company, supported by strong execution of its BD 2025 strategy. The company's continued emphasi...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.